AmInvest Research ups earnings outlook for Luxchem


AmInvest Research said Luxchem’s 9MFY20 results came in above expectations, accounting for 80% and 79% of its full-year forecasts and fullyear consensus estimates respectively.

KUALA LUMPUR: AmInvestment Research raised its FY20 to FY22F net profit forecasts for Luxchem by 15%, 26% and 26% respectively and raised its fair value by 25% to 79 sen from 63 sen previously.

In its research note issued on Wednesday, it saw the fair value was based on 14 times FY21F EPS, valuing the stock at two times multiple premium to its average historical forward price-to-earnings of 12 times.

Limited time offer:
Just RM5 per month.

Monthly Plan

RM13.90/month
RM5/month

Billed as RM5/month for the 1st 6 months then RM13.90 thereafters.

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In Business News

Trade showing remains on upward trajectory
Maxis pledges full support to government’s 5G delivery model
Fajarbaru Builder secures RM13mil job
MKH Oil Palm IPO oversubscribed
The pros and cons of earned wage access
Making every load lighter
Making the Malaysian startup pitch
How Sin-Kung leveraged air cargo for its success
Domestic office-sector REITs stay cautious
‘Muted optimism’

Others Also Read